VEGFA and neoplasm: The clinical relevance of PKARIα has already been shown for tumor-, vascular endothelial growth factor (VEGF)-, and ischemia-induced angiogenesis (19) as well as for platelet-derived growth factor (PDGF) signaling pathways in renal mesangial cells (20).